Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

NCT05650333 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

NCT07200128 ·Status: COMPLETED

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

NCT06873945 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

NCT07029711 ·Status: RECRUITING ·Phase: PHASE3

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

NCT02553330 ·Status: TERMINATED ·Phase: PHASE2

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

NCT02974868 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia

NCT03048461 ·Status: WITHDRAWN ·Phase: PHASE2

Litfulo Capsules Special Investigation

NCT06279221 ·Status: ACTIVE_NOT_RECRUITING

A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.

NCT07152119 ·Status: RECRUITING

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

NCT05556265 ·Status: TERMINATED ·Phase: PHASE2

Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study

NCT05129800 ·Status: COMPLETED

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

NCT03570749 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Platelet Rich Plasma for Frontal Fibrosing Alopecia

NCT03335228 ·Status: WITHDRAWN ·Phase: NA

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

NCT06240351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

NCT03899259 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia

NCT02074943 ·Status: UNKNOWN ·Phase: NA

Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study

NCT06797310 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

NCT05332366 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata

NCT05599607 ·Status: COMPLETED ·Phase: NA

Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata

NCT05255237 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients

NCT06440655 ·Status: RECRUITING ·Phase: NA

Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP

NCT05251831 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

NCT03495817 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata

NCT05051761 ·Status: COMPLETED ·Phase: PHASE3

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

NCT03759340 ·Status: TERMINATED ·Phase: PHASE2